1. Introduction {#sec1}
===============

Hox genes encode transcription factors containing a 61-amino acid motif that enables binding and transcriptional regulation of target gene expression \[[@B1]--[@B3]\]. The mammalian Hox genes have 39 members organized in four clusters (HoxA-D) each located on a different chromosome. Resulting from successive duplications during the evolution of an ancestral Hox complex, each cluster contains a series of paralogues (groups I--XIII). Each *Hox* gene has a conserved helix-turn-helix DNA-binding domain that recognizes and binds to specific sequence motifs (TAAT/ATTA/TTAT/ATAA) located in promoter sequences, intergenic and intronic regions. Such conserved sequence motif is also found repeatedly several times in the genome underscoring a potentially expansive regulatory landscape of Hox genes \[[@B4], [@B5]\]. Hox expression domains along the anterior-posterior (A-P) axis is characterized as overlapping, with the order and timing of expression correlating to the position of genes along a cluster. The combinatorial expression of various *Hox* genes constitutes the proverbial "Hox code": the genetic program that determines cell fates, that is, morphogenesis, growth, and differentiation during embryonic development \[[@B6]\]. Meanwhile, in adult cells, *Hox* genes assume some poorly understood oncogenic roles. For example, expression of *HOXC5* and *HOXC8* is selectively elevated in human cervical cancer cells when compared to normal keratinocytes \[[@B7]\]. In human prostate adenocarcinomas, *HOXC8* expression is directly correlated with the loss of tumor differentiation based on Gleason scoring \[[@B8]\]. Moreover, Hox genes have been ascribed with "nonconventional" roles such as postnatal neuronal circuit development \[[@B9]\] although data is still scant.

To gain better understanding of the mechanisms by which Hox functions during mouse embryogenesis, the identification and functional analysis of target genes are necessary. In this study, we focused our analysis on the downstream targets of *Hoxc8*, one of three members of the paralogous group VIII, which our group and other laboratories have extensively studied in the past years \[[@B6], [@B10]--[@B13]\]. Several molecular tools have allowed us to identify the developmental regulatory targets of Hoxc8 in a high-throughput manner. Microarray expression analysis by the group of Frank Ruddle has identified 34 genes involved in cell adhesion, migration, metabolism, and apoptosis whose expression levels were differentially changed in mouse embryonic cells overexpressing Hoxc8 \[[@B6]\]. Likewise, our group identified, using proteomics, 15 genes associated with cell motility, protein homeostasis, and metabolism \[[@B14]\]. More recently, modified chromatin immunoprecipitation- (ChIP-) based methods have been developed, such as ChIP-cloning, ChIP Display, Differential Chromatin Scanning, and ChIP-chip and DamID chromatin profiling, permitting the screening for DNA-protein interaction in vivo at a genome-wide scale \[[@B15]\]. We took advantage of a ChIP-cloning gene discovery strategy \[[@B16]\] to search for novel downstream target genes of Hoxc8 that may be important during mouse development. We identified 12 putative target sites by ChIP-cloning and subjected these to comparative genomics analysis to identify Hoxc8-binding motifs that are conserved across the mammalian lineage leading to the identification of *Zfp804a*, as a strong candidate target. We further confirm the regulation of *Zfp804a* by ChIP-PCR, coexpression analysis and a reporter assay.

2. Materials and Methods {#sec2}
========================

2.1. Animal Preparation {#sec2.1}
-----------------------

In order to get E11.5 embryos, ICR mice were allowed to mate at 6:00 pm, and presence of a vaginal plug in the following morning indicates the 0.5 day post coitum (dpc) time point. After 11 days, the pregnant mice were sacrificed and E11.5 embryos were taken. Maternal and extraembryonic tissues were removed.

2.2. Cell Culture and Transfection {#sec2.2}
----------------------------------

F9 cells were cultured in DMEM media supplemented with 10% of fetal bovine serum (FBS) and 100 *μ*g/ml penicillin-streptomycin (Invitrogen, Carlsbad, CA, USA) in plates that were coated with 0.1% gelatin. The cells were incubated at 37°C in a 5% CO~2~ environment. In 100 mm dishes, upon reaching \~50%, the cells were transfected with 4 *μ*g of pcDNA3 (empty vector control) or pcDNA3:Hoxc8 plasmid DNA using Lipofectamine 2000 system (Invitrogen).

2.3. ChIP Assays {#sec2.3}
----------------

ChIP assays were performed on fresh E11.5 embryos with the head and internal organs removed using a ChIP assay kit (Upstate Biotechnolgy, Lake Placid, NY, USA) with slight modification. To enrich specificity, immunoprecipitation step was performed thrice using a Hoxc8-monoclonal antibody (MMS-266R, Covance Research products, Princeton, NJ, USA). Immunoprecipitation in the absence of the antibody served as negative control. ChIP-DNA was cloned into pBluescriptII SK(+) vector and its inserts were sequenced \[[@B17]\]. We reported our identification of Hoxc8 gene targets using this ChIP-cloning protocol in our previous paper \[[@B10]\].

In order to verify whether the identified genes are a target of Hoxc8, we PCR-amplified fragments from ChIP-DNA of E11.5 embryos and F9 cells using the primers F, 5′ggagtcacaaccaaatctgc  3′ and R, 5′cagggaattttgggcattat  3′. PCR was carried out with a 5-minute hot start at 94°C, followed by 33 cycles of denaturation (94°C for 1 minute), annealing (1 minute at 55°C), and extension (1 minute at 72°C).

2.4. RNA Isolation and RT-PCR {#sec2.4}
-----------------------------

Total cellular RNA was extracted with RNAzol Bee (Tel-test, Inc. Industries Inc., Texas, USA), partitioned with chloroform/isoamyl alcohol and centrifuged at 12 000 rpm at 4°C for 15 minutes. RNA was precipitated by adding equal volume of cold iso-propanol and centrifugation at 12 000 rpm at 4°C for 15 minutes. Pellet was washed with 70% ethanol, air-dried, and resuspended in DEPC-H~2~O. RT-PCR was performed on 2 *μ*g of the RNA with the following PCR conditions: 5 minutes hot start at 94°C, followed by denaturation at 94°C for 1 minute, annealing step at the specific temperatures for 50 seconds (*β-actin*, 56°C, *Hoxc8*, 56°C, and *Zfp804a*, 55°C), and extension step at 72°C for 1 minute for 28 cycles. Each reaction was terminated after a final elongation step of 72°C for 7 minutes. The sequences of the primers were as follows: **β*-actin*(F, 5′catgtttgagaccttcaacacccc  3′; R, 5′gccatctcctgctcgaagtctag3′), *Hoxc8*(F, 5′cctattacgactgccggttc3′; R, 5′ttggcggaggatttacagtc  3′), and *Zfp804a*(F, 5′tcacaagggacccatcaaat3′; R, 5′ttagcatgttcggctgaatg  3′).

2.5. Effector-Reporter Assay {#sec2.5}
----------------------------

An effector-reporter assay was done using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA). *Zfp804a* gene fragment was cloned into the pGL3MP vector \[[@B18]\] to make the effector-reporter construct. For the luciferase assay, 2 × 10^5^ F9 cells/well were seeded into a 6-well plate and cultured until 50% of confluency. Four micrograms of effector (pcDNA3:Hoxc8; pcDNA3:Hoxc8 +siHoxc8) were cotransfected in the cells with 1 *μ*g of the reporter (pGL3-MP; pGL2-MP:*Zfp804a*) and 25 ng of pRL-TK vectors. After 36 hours, the cells were lysed and luciferase activity was measured using the GLOMAX 20/20 luminometer (Promega).

3. Results and Discussion {#sec3}
=========================

*Hox* genes play a role as a "realisator" of body pattern formation \[[@B2], [@B3]\]. Since the discovery of *Drosophila Hox* genes in the early 1980s, there has been an avalanche of studies on their roles in mammalian development. However, while much is already known about *Hox* gene structure and its function, how it determines the precise formation of the body parts along the A-P axis is still enigmatic. In order to gain further insight into the molecular basis of how various *Hox* genes control tissue fate, it is necessary that their downstream genes are identified and characterized.

We obtained target genes of Hoxc8 by ChIP-cloning \[[@B10]\] and further demonstrated regulation of a candidate gene. ChIP-cloning approach is a modification of the ChIP assay which combines immunoprecipitation of sheared chromatin with subsequent DNA cloning and sequencing ([Figure 1](#fig1){ref-type="fig"}). In our ChIP-cloning procedures, we used E11.5 mouse embryos because Hoxc8 expression is relatively elevated at this particular stage compared to other time points \[[@B10]\]. After removal of the head and internal organs, the embryo was fixed with formaldehyde to cross-link DNA-protein interactions. After the DNA complexes were pulled down by an anti-Hoxc8 monoclonal antibody, purified ChIPed DNA fragments were cloned and sequenced. Out of 146 clones, we identified 12 candidate genes from 16 sequences, most of which contained Hox-binding motifs (see [Table 1](#tab1){ref-type="table"}). As it is logical to assume that Hox-binding will likely occur in the promoter regions of its target genes, in our experiment, all our cloned DNA fragments were derived from intronic and intergenic regions. A similar observation was reported by Birkaya et al. \[[@B19]\] showing that \>40% of DeltaNp63-ChIP fragments were from the introns. One of the cloned regions of our candidate targets, calpain 10 (NM_011796.2), does not have a Hox-binding motif implying that if this was confirmed as true target, Hoxc8 may likely regulate the gene via indirect binding, probably in collaboration with a cofactor(s), as in the case of TGF-*β* signaling with Hoxc8 \[[@B20]--[@B22]\]. Among the candidate genes, we chose to study zinc finger protein 804a (*Zfp804a*; NM_175513) since this cloned intronic region contains \~8.4 Hox-binding sites per 100 bp. In subsequent in silico analysis, however, out of the 75 Hox-binding motifs present, only 4 were conserved across a wide range of mammalian species: human, chimpanzee, rhesus, orangutan, marmoset, cat, horse, dog, opossum, mouse, rat, and guinea pig.

To further demonstrate *Zfp804a*-Hoxc8-binding, we validated the interaction by performing ChIP-PCR on cell extracts from Hoxc8-overexpressing F9 murine embryonic teratocarcinoma cell line (in vitro) and E11.5 mouse embryos (in vivo). Located in chromosome 2, the *Zfp804a* gene contains 4 coding exons with a noncontiguous string of Hoxc8-binding motifs within its first intron. We designed primers to target the area where putative Hox-binding sites are abundant ([Figure 2(a)](#fig2){ref-type="fig"}). *Zfp804a* gene was clearly amplified from the DNA samples that had been precipitated by a commercial monoclonal ([Figure 2(b)](#fig2){ref-type="fig"}) and an in-house polyclonal antibody (data not shown) but not by an antimouse IgG. The strongest band of *Zfp804a* among 12 candidate genes in ChIP-PCR led us to focus our analysis on it (data not shown). The *Zfp804a* band was also detected from input lane which served as the internal control. Our results, therefore, indicate that the Hoxc8 protein stably and directly binds to the first intron of*Zfp804a*.

Does this binding lead to a modulation of gene expression? Given the fact that the regulation of *Zfp804a* is largely unknown, we utilized an unbiased effector-reporter assay by cloning the *Zfp804a*intronic fragment into the minimal promoter plasmid, pGL3-MP (pGL3-MP:*Zfp804a*). With transfection into F9 cells and assaying for dual-luciferase activity after 36 hours, enhancement of promoter activity relative to pGL3-MP was seen when Hoxc8 expression plasmid was cotransfected compared with the empty vector (pcDNA3 alone). In addition, we were able to demonstrate that the augmented promoter activity was abolished by adding Hoxc8 siRNA ([Figure 2(c)](#fig2){ref-type="fig"}). These data suggest that the intronic fragment of *Zfp804a*may function as an alternative promoter, and the modulation of activity of the minimal promoter \[[@B18]\] by such intronic sequence endorses the functionality of the Hoxc8-*Zfp804a* interaction.

Finally, we studied whether Hoxc8 modulates expression of *Zfp804a*. For this, we transiently transfected with a Hoxc8 overexpression construct F9 cells having undetectable levels of Hoxc8 and *Zfp804a* mRNAs. Compared with the empty vector control, the cells overexpressing *Hoxc8* showed induction of *Zfp804a*([Figure 3(a)](#fig3){ref-type="fig"}) indicating that, in this particular in vitro system, expression of *Zfp804a* was positively regulated by Hoxc8. To prove in vivo, we analyzed levels of *Hoxc8* and *Zfp804a*mRNA transcripts along the A-P axis of E11.5 embryos. From [Figure 3(b)](#fig3){ref-type="fig"}, *Hoxc8* was expressed in the trunk area (regions 3 to 5) except in head whereas *Zfp804a* mRNA was seen generally through-out the trunk with only a residual signal in the head area ([Figure 3(b)](#fig3){ref-type="fig"}) \[[@B23]\]. Thus, the expression patterns on *Zfp804a*correlate to some extent with that of *Hoxc8*in this developmental stage. Since the regulation target genes by Hox is complex and multifactorial \[[@B24], [@B25]\], we are cautious in interpreting such data since Hox regulates its target in a context-dependent manner and proves to be both a repressor and activator at the same time \[[@B26]\].

An interesting twist in the relationship of Hoxc8-*Zfp804a* regulation lies in the recent discovery that its human homologue, *ZNF804A,* turns out to be a marker for schizophrenia and bipolar disorders \[[@B27]\]. Although *ZNF804A*is uncharacterized and its functions are still unknown to date, it is interesting that fMRI images of *ZNF804A* SNPs carriers show altered functional coupling between the dorsolateral prefrontal cortex (DLPFC) and the hippocampus \[[@B28]\]. Since genetic variation in dopaminergic and glutaminergic neurotransmission affects DLPFC or hippocampus connectivity, the examination of ZNF804A and HOXC8 in these neurotransmitter cascades would be interesting in the future. During embryogenesis, Hox gene expression is activated prior to rhombomeric segmentation, and its anterior boundaries, limited to those in the paralogue groups I--IV, are found only in the neuroepithelia that give rise to the hindbrain \[[@B29]\]. Because of this bias, no systematic study on neurobiology of the other Hox paralogues has been done. Therefore, the finding here is rather surprising and very intriguing.

Recently, some *HOX* genes have been reported to be expressed in adult cells, and misexpression of certain *HOX* gene(s) can lead to diseases such as cancer \[[@B30]\]. Therefore we examined the expression of Hoxc8 in adult mouse brain. As shown in [Figure 3(c)](#fig3){ref-type="fig"}, we were also able to verify the expression of *Hoxc8* in adult normal brain tissue, cortex, and hippocampus by RT-PCR. Interestingly, *Zfp804a*was only detected in cortex, but not in hippocampus. Consistent with this expression patterns, Hoxc8 showed a prominent binding to *Zfp804a* in cortex as well as whole brain ([Figure 3(d)](#fig3){ref-type="fig"}).

Given that Hox genes are master transcription factors at the apex of the genetic hierarchy of developmental control, it is tantalizing to regard that their "fetal" molecular networks would extend influence to adulthood and more so, in such complex systems, such as psychosis. A future challenge from our work is to elucidate the molecular mechanisms responsible for this phenomenon and the potential implications of Hox regulatory control in human behavior.
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![ChIP-cloning flow chart. The procedure of ChIP methods is based on Upstate manufacture\'s instructions. The embryos (E11.5) and F9 cells were prepared for ChIP-cloning as detailed above.](JBB2010-231708.001){#fig1}

![The mouse *Zfp804a* gene is located in chromosome 2 and has Hoxc8 responsive elements in the intron1 region. (a) *Zfp804a* gene organization. Coding regions or exons (black box) and the introns (grey box) are shown. Hoxc8-binding core sequences are shown in bold and the underlined sequences indicate primer targets for ChIP-PCR. (b) A ChIP experiment was performed using mouse E11.5 embryos and F9 cell line. The DNA-Hoxc8 complexes were immunoprecipitated by a Hoxc8-monoclonal antibody (lane 4). Input (prior to immunoprecipitation) was used for an internal control (lane 1), and mouse IgG and vehicle were used as a negative control (lane 3-4). (c) Hoxc8 activates*Zfp804a* in the effector-reporter assay. Luciferase construct is driven by a minimal promoter fused to the intronic segment of *Zfp804a* (pGL3-MP : *Zfp804a*; reporter) and cotransfected with a empty vector pcDNA3, pcDNA3:Hoxc8 (effector), and a siRNA for Hoxc8 in F9 cells. Thirty-six hours after transfection, luciferase activities were measured. The experiments were performed in 3 independent trials. The mean values of the luciferase activity are shown as fold change relative over that of the pcDNA3.](JBB2010-231708.002){#fig2}

![RT-PCR analysis of the *Zfp804a* gene expression in vitro and in vivo. Total cellular RNA was isolated (a) in vitro with F9 cells transfected with pcDNA3 vector (control) and Hoxc8 overexpression vector and (b) in vivo, from mouse E11.5 embryos. (c) Total cellular RNA was isolated from mouse adult whole brain, cortex, and hippocampus (males, 6 weeks old). (d) A ChIP experiment was performed using mouse adult whole brain, cortex, and hippocampus. The DNA-Hoxc8 complexes were immunoprecipitated by a Hoxc8 monoclonal antibody (lane 2). Input (prior to immunoprecipitation) was used for an internal control (lane 1), and mouse IgG and vehicle were used as a negative control (lane 3-4) and DW (lane 5).](JBB2010-231708.003){#fig3}

###### 

Candidate downstream targets of Hoxc8 from ChIP-cloning. Referred to Chung HJ et al. \[[@B10]\].

  ACCN no.         Gene name                                                                             No. of Hox-binding motifs   Chromosome   Location            Molecular/cellular function
  ---------------- ------------------------------------------------------------------------------------- --------------------------- ------------ ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  NM_175513        zinc finger protein 804A                                                              75                          2            intron 1            zinc ion binding; metal ion binding
                                                                                                                                                                      
  NM_001085495     ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldinA-inhibited)   22                          2            intron 1            ARF guanyl-nucleotide exchange factor activity; binding; myosin binding; exocytosis; intracellular signaling cascade; regulation of ARF protein signal transduction
                                                                                                                                                                      
  NW_001030820     118.3 kb at 5′ side: hypothetical protein                                                                                                          unknown
                                                                                                         20                          6            intergenic region   
  XM_920612.2      22 kb at 3′ side: Similar to lanin A-related sequence 1 protein isoform 2                                                                          unknown
                                                                                                                                                                      
  NM_028533.2      47 kb at 5′ side: hypothetical protein LOC 73410                                                                                                   unknown
                                                                                                         20                          9            intergenic region   
  NM_011916.2      50 kb at 3′ side: 5′-3′ exoribonuclease 1                                                                                                          5′-3′ exonuclease and hydrolase activities
                                                                                                                                                                      
  NM_080788.3      tau tubulin kinase 2 isoform 1,2                                                      16                          2            intron 10           nucleotide binding; protein serine/threonine kinase activity; ATP binding; transferase activity
                                                                                                                                                                      
  NM_153386.2      Usher syndrome 3A homolg isoform 1,2                                                  13                          3            intron 1            sensory perception of sound; photoreceptor cell maintenance; equilibrioception
                                                                                                                                                                      
  NM_172964.3      134 kb at 5′ side: Rho GTPase activating protein 28                                                                                                GTPase activator activity
                                                                                                         11                          17           intergenic region   
  NM_177278.3      221 kb at 3′ side: hypothetical protein LOC320858                                                                                                  unknown
                                                                                                                                                                      
  NM_172825.2      G protein-coupled receptor 128                                                        10                          16           intron 4            neuropeptide signaling pathway; G-protein coupled receptor activity
                                                                                                                                                                      
  NM_001083919.1   139 kb at 5′ side: Cardiomyopathy associated 3 isoform 2                                                                                           unknown
                                                                                                         10                          2            intergenic region   
  NM_020283.2      459 kb at 3′ side: UDP-Gal:*β*GlcNAc *β*1,3-galatosyl transferase                                                                                  protein amino acid glycosylation; oligosaccharide biosynthetic process; lipid glycosylation
                                                                                                                                                                      
  NM_013600        mutS homolog 5                                                                        8                           17           intron 11           nucleotide binding; DNA binding; protein binding; ATP binding; mismatched DNA binding; NF-kappaB binding
                                                                                                                                                                      
  NM_008960.2      phosphatase and tensin homolog                                                        4                           19           intron 5            phosphatidylinositol-3-phosphatase activity; protein serine/threonine phosphatase activity; PDZ domain binding
                                                                                                                                                                      
  NM_011796.2      calpain 10                                                                            0                           1            intron 5/exon 6     SNARE binding; calcium-dependent cysteine-type endopeptidase activity; cytoskeletal protein binding; peptidase activity
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